Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
45 participants
INTERVENTIONAL
2025-04-01
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Intervention for Inflammatory Bowel Disease Remission
NCT05920187
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181
Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease.
NCT05230160
Diet Treatment of Patients With Ulcerative Colitis in Remission
NCT02469220
Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD
NCT05382897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intermittent Fasting
Participants will be assigned to follow an intermittent fasting protocol.
No interventions assigned to this group
Mediterranean Diet
Participants will be assigned to follow a Mediterranean diet.
No interventions assigned to this group
Low FODMAP Diet
Participants will be assigned to follow a Low FODMAP Diet.
Low FODMAP Diet Intervention
A diet limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage gastrointestinal symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent Fasting Intervention
A 14:10 intermittent fasting regimen, where participants fast for 14 hours and consume all meals within a 10-hour eating window daily.
Mediterranean Diet Intervention
A diet emphasizing whole grains, fruits, vegetables, olive oil, lean proteins, and minimizing processed foods.
Low FODMAP Diet Intervention
A diet limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage gastrointestinal symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having willingness to use their personal smartphone to access the app
* Able to understand the indication by the registered dietitian.
* Able to provide informed consent.
* Willingness to attempt intervention diet and commit to study procedures.
Exclusion Criteria
* Currently being treated for eating disorders, schizophrenia, psychosis, or other acute mental disorders.
* Currently being treated for chemotherapy.
* Diabetes
* Advance chronic kidney disease
* Short bowl syndrome
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Armstrong
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2F Digestive Diseases Clinic - Hamilton Health Science
Hamilton, Ontario, Canada
McMaster University
Hamilton, Ontario, Canada
McMaster University
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB #18028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.